Translational and Clinical Trial Correlates Core
Translational and Clinical Trial Correlates Core
批准号:
10526306
负责人:
Claudia Marcela Diaz-Montero
金额:
$45.44万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-14 至 2027-07-31
关键词:
Bar CodesBioinformaticsBiological AssayBiological MarkersBiometryCell SurvivalCellsChairpersonClinicalClinical ResearchClinical TrialsCollaborationsCombined Modality TherapyComputational BiologyDataData AnalysesData CollectionData Management ResourcesEnsureFlow CytometryGenerationsGenesGenomicsHealth SciencesImmunogenomicsImmunologic MonitoringImmunologicsImmunologyImmunology procedureImmunooncologyImmunophenotypingImmunotherapyInstitutesLaboratoriesMolecularMutationPathologicPathologyPathway AnalysisPathway interactionsPerformancePeripheral Blood Mononuclear CellPlasmaProceduresProcessProteomicsQuality ControlRadiationReportingResearch DesignResearch PersonnelResearch Project GrantsResourcesSamplingSequence AnalysisSpecimenStandardizationStatistical Data InterpretationT-LymphocyteT-cell receptor repertoireTechnologyTissue ProcurementsTreatment EfficacyTumor TissueWhole Bloodbasebiobankcomputing resourcesdata harmonizationdata managementdata resourcedifferential expressionhuman leukocyte antigen testinginteroperabilitymultidisciplinaryneoantigenspreclinical studyprogramsradiation responseradiomicsresponsescreeningtranscriptometranscriptomicstranslational clinical trialtranslational goaltreatment response
中文摘要
项目总结
翻译与临床相关核心(TCCC)的目标是提供所需的专业知识和资源
对我们的研究项目和临床研究项目进行质量相关分析
罗宾计划。为了做到这一点,我们组建了一个拥有组织专业知识的多学科团队。
采购和生物库、免疫分析、免疫基因组学、蛋白质组学、放射组学和最新技术
计算生物学和生物统计学方法。在目标1中,TCCC将提供高度标准化和
采购、加工和生物库标本的有效程序。这将确保提供经过良好编目的
以及具有最佳细胞活力的临床注释样本。在AIM 2中,TCCC将促进访问-
-ART平台,用于全面的分子、病理和免疫学分析
生物群落。这将提供对响应的变化的广泛的分子评估
治疗及其对反应的贡献。在AIM 3中,TCCC将提供接触尖端技术的途径
用于处理、分析和解释高通量数据的计算资源。进阶
生物信息学将由免疫治疗和精密免疫肿瘤学中心提供
计算免疫学平台,定量健康科学部将协助
统计分析。为协调各参与机构的数据管理和分析工作
将有一名指定的数据资源管理员(CC为卡坦/埃默里为Switchenko)。这个集中式
该方法将确保在项目和临床研究之间进行最佳的数据收集、分析和共享。
英文摘要
PROJECT SUMMARY
The goal of the Translational & Clinical Correlates Core (TCCC) is to provide the expertise and resources needed
to conduct quality correlative analyses for the research projects and clinical studies proposed as part of our
ROBIN Program. To accomplish this, we have assembled a multidisciplinary team with expertise in tissue
procurement and biobanking, immune assays, immunogenomics, proteomics, radiomics, and state-of-the-art
computational biology and biostatistics approaches. In Aim 1, the TCCC will provide highly standardized and
validated procedures to procure, process and biobank specimens. This will ensure availability of well-catalogued
and clinically annotated samples with optimal cell viability. In Aim 2, the TCCC will facilitate access to state-of-
the-art platforms for the comprehensive molecular, pathologic, and immunologic profiling of collected
biospecimens. This will provide a broad molecular assessment of the changes that occur in response to
treatment and their contributions to response. In Aim 3, the TCCC will provide access to cutting-edge
computational resources for the processing, analysis and interpretation of high-throughput data. Advanced
bioinformatics will be provided by the Center for Immunotherapy and Precision Immuno-Oncology’s
Computational Immunology Platform, and the Department of Quantitative Health Sciences (QHS) will assist with
the statistical analyses. To facilitate harmonization of data management and analysis each participating institute
will have a designated Data Resource Manager (Kattan for CC/Switchenko for Emory). This centralized
approach will ensure optimal data collection, analysis, and sharing among projects and clinical studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of cancer immunotherapy-associated thrombosis
-
批准号:10667046
-
项目类别:
-
资助金额:$72.14万
-
财政年份:2023
-
负责人:Claudia Marcela Diaz-Montero
-
依托单位:
Translational and Clinical Trial Correlates Core
-
批准号:10704716
-
项目类别:
-
资助金额:$29.82万
-
财政年份:2022
-
负责人:Claudia Marcela Diaz-Montero
-
依托单位:
Programming T Cells for Successful Adoptive Cell Therapy
-
批准号:7934010
-
项目类别:
-
资助金额:$12.78万
-
财政年份:2009
-
负责人:Claudia Marcela Diaz-Montero
-
依托单位:
Programming T Cells for Successful Adoptive Cell Therapy
-
批准号:8305696
-
项目类别:
-
资助金额:$13.06万
-
财政年份:2009
-
负责人:Claudia Marcela Diaz-Montero
-
依托单位:
Programming T Cells for Successful Adoptive Cell Therapy
-
批准号:8782916
-
项目类别:
-
资助金额:$13.06万
-
财政年份:2009
-
负责人:Claudia Marcela Diaz-Montero
-
依托单位:
Programming T Cells for Successful Adoptive Cell Therapy
-
批准号:8531675
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Claudia Marcela Diaz-Montero
-
依托单位:
Programming T Cells for Successful Adoptive Cell Therapy
-
批准号:8133731
-
项目类别:
-
资助金额:$13.06万
-
财政年份:2009
-
负责人:Claudia Marcela Diaz-Montero
-
依托单位:
Programming T Cells for Successful Adoptive Cell Therapy
-
批准号:7741444
-
项目类别:
-
资助金额:$12.5万
-
财政年份:2009
-
负责人:Claudia Marcela Diaz-Montero
-
依托单位:
海外基金